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Bestrophin-1 is preferentially expressed at the basolateral membrane of the retinal pigmented epithelium (RPE) of the retina. Mutations
in the BEST1 gene cause the retinal dystrophies vitelliform macular dystrophy, autosomal-dominant vitreochoroidopathy, and auto-
somal-recessive bestrophinopathy. Here, we describe four missensemutations in bestrophin-1, three that we believe are previously unre-
ported, in patients diagnosed with autosomal-dominant and -recessive forms of retinitis pigmentosa (RP). The physiological function
of bestrophin-1 remains poorly understood although its heterologous expression induces a Cl-speciﬁc current. We tested the effect
of RP-causing variants on Cl channel activity and cellular localization of bestrophin-1. Two (p.L140V and p.I205T) produced signiﬁ-
cantly decreased chloride-selective whole-cell currents in comparison to those of wild-type protein. In a model system of a polarized
epithelium, two of three mutations (p.L140V and p.D228N) caused mislocalization of bestrophin-1 from the basolateral membrane
to the cytoplasm. Mutations in bestrophin-1 are increasingly recognized as an important cause of inherited retinal dystrophy.Introduction
Human bestrophin-1 (MIM 607854) is one of a family of
four transmembrane proteins and is primarily expressed
in the retinal pigment epithelium (RPE).1–4 The family
was originally deﬁned from over 20 related sequences
in Caenorhabditis elegans,5 and orthologs exist down to
bacteria.6 The conservation of their transmembrane
domains suggest that bestrophins perform a common crit-
ical function.6 Considerable evidence shows that bestro-
phins act as chloride channels: exogenous expression in
various cell lines induces a newCl current,1 the paralogues
havedifferent biophysical properties,5 and endogenousCl
currents can be modiﬁed by knockdown of bestrophin-1
expression.7 However there is also evidence that human
bestrophin-1 can regulate voltage-gated Ca2þ channels in
an RPE cell line.8 This raises the possibility that bestro-
phin-1 may be a channel and a channel regulator.9 Such a
dual function has been reported for the cystic ﬁbrosis trans-
membrane conductance regulator (CFTR [MIM 602421])
which functions as a chloride channel10 and regulates
transport proteins, e.g., chloride-coupled bicarbonate
transporters11 and the epithelial sodium channel.12
Given the localization of bestrophin-1 to the RPE, it has
been suggested that it is responsible for generating, or at
least modulating, the light peak of the electrooculogram
(EOG).1,13 The light peak is thought to be due to the activa-
tion of a Cl conductance at the basolateral membrane of
the RPE,14 and it is used in the clinical assessment of RPE
health and function. Abnormal EOGs are characteristic ofThe Americathe bestrophinopathies, the ﬁrst of which was vitelliform
macular dystrophy (VMD [MIM 153700], also known as
Best disease), in which yellow material accumulates under
the retina andRPE in the area of themacula so that it resem-
bles an egg yolk (vitelliform).6 We have described the
molecular cause of other retinopathies caused by BEST1
mutations. In autosomal-dominantvitreoretinochoroidop-
athy (ADVIRC [MIM 193220]), missense mutations cause
the expression of an isoform lacking an internal exon in
addition to the full-length missense isoform.15 The condi-
tion had been clinically described previously, and as the
name suggests, it consists of retinal and vitreal ﬁndings.16
Subsequently, we described the previously unreported
phenotype of autosomal-recessive bestrophinopathy (ARB
[MIM 611809]), a condition that represents the human
bestrophin-1null phenotype inone familywith the charac-
teristic phenotype and homozygous nonsense muta-
tions.17 In addition to having an abnormal EOG, patients
alsohaveabnormal electroretinograms (ERG) anda retinop-
athy that includes an abnormal RPE, frequently with
scattered punctate ﬂecks. A recently described condition,
canine multifocal retinopathy, is likely to be the naturally
occurring equivalent of ARB in dogs.18
In this study, we report four missense mutations in
BEST1, three previously unreported, that have been identi-
ﬁed in patients diagnosed with retinitis pigmentosa (RP) in
ﬁve unrelated families. The phenotypic heterogeneity
associated with BEST1 is becoming increasingly compli-
cated, with ﬁve separate ocular diseases now being ascribed
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and autosomal-dominant RP [adRP]). Although the inci-
dence of each of these bestrophinopathies is individually
rare, the increasing number of phenotypes associated
with BEST1 mutations suggests that these mutations are
an increasingly important cause of genetic ocular disease.
To our knowledge, this is the ﬁrst report of mutations in
an RPE gene as a cause of adRP.
Subjects and Methods
Patient Details
The study was approved by research ethics committees at Man-
chester Royal Eye Hospital. Informed consent was obtained from
all participants prior to the investigations. Clinical examination
of selected members of the affected families included visual acuity
testing, fundus examination and photography, and autoﬂuores-
cence imaging. Electroretinogram testing on families 1, 2, and 5
was performed in accordance with the standards of the Interna-
tional Society for Clinical Electrophysiology of Vision (ISCEV).
Electrooculogram testingwas not performed on any of the families
because of the extinguished or greatly reduced ERGs (where
recorded).
Blood was taken from all family members by venesection, and
genomic DNA was extracted via standard procedures.
SNP Microarray and Linkage Analysis of Family 1
Whole-Genome Amplification
Whole-genome ampliﬁcation was used for those samples that did
not contain theminimumamount of DNA required formicroarray
analysis. Ampliﬁcation reactions were set up with the use of the
REPLI-g Mini Kit (QIAGEN, Crawley, West Sussex, UK), in accor-
dance with the manufacturer’s instructions. Samples were incu-
bated at 30C for 16 hr.
SNP Microarray and Linkage Analysis
SNP genotyping was carried out with the use of Affymetrix
Genechip 250K Nsp Arrays (Affymetrix, HighWycombe, Bucking-
hamshire, UK). DNA was prepared in accordance with the manu-
facturer’s instructions and hybridized onto the array at 49C for
16–18 hr. Staining of the arrays was carried out with the Affyme-
trix Fluidics Station 450, followed by scanning performed with
the Affymetrix Genechip Scanner 3000 7G system.
Genotypes were called with the Bayesian Robust Linear Model
with Mahalanobis (BRLMM) algorithmwithin the GTYPE 3.1 soft-
ware provided by Affymetrix, with amodiﬁed call threshold of 0.1.
Files for linkage analysis withMerlin19 were produced with the use
of the SNP Export Tool within the GTYPE 3.1 software.
Parametric linkage analysis was carried out with the Merlin soft-
ware package. So that accuracy would be increased, ﬁles were
ﬁltered for the removal of unlikely genotypes with the use of the
error-detection facility within Merlin prior to linkage analysis.
Parametric linkage analysis was carried out with the use of a fully
penetrant dominant model with a disease-allele frequency of
0.01% and a phenocopy rate of 0.01%. Merlin was also used for
generating haplotypes, which were then viewed with Haplo-
view.20
DNA Sequencing
All ten coding exons and ﬂanking intronic boundaries were
sequenced in each of the ﬁve family probands with the use of
methods and primers as previously described.17 The relevant582 The American Journal of Human Genetics 85, 581–592, Novemexon containing the sequence alteration was sequenced in
other family members as indicated in the Results section and in
Figure 1. The absence of the three previously unreported muta-
tions (c.418c>g, c.614t>c, and c.682g>a) in 210 ethnically
matched control chromosomes (white of European descent for
families 1–4 and Pakistani for family 5) was conﬁrmed by single-
strand conformation polymorphism (SSCP), performed as previ-
ously described,17 giving a power of 80%.21 The cDNA is numbered
according to Ensembl transcript ID ENST00000378043, in which
þ1 is the A of the translation start codon.
Multiple alignment of human bestrophin-1 and nine orthologs
was performed with ClustalW at BioEdit.
Cloning
Wild-type (WT) BEST1 in pAdlox was a kind gift from A Marmor-
stein (University of Arizona, USA). Additional mutant constructs
for p.L140V, p.I205T, and p.D228Nwere generated by site-directed
mutagenesis with the use of the QuickChange II Kit (Stratagene,
Stockport, Cheshire, UK) in accordance with the manufacture’s




Human embryonic kidney 293 (HEK293) cells were cultured in
minimum essential mediumwith Earle’s salt and L-glutamate con-
taining 9% fetal calf serum, 1% (v/v) nonessential amino acids,
gentamicin (0.2 mg/ml), and penicillin G (100 U/ml) (all Invitro-
gen) at 37C and 5% CO2. Madin-Darby canine kidney II (MDCK
II) cells were cultured in Dulbecco’s Modiﬁed Eagle Medium con-
taining L-gultamine, D-glucose (4500 mg/l), and sodium pyruvate
(110 mg/l) (Invitrogen) supplemented with 10% (v/v) fetal calf
serum, 5% (v/v) penicillin/streptomycin, and 1% (v/v) nonessen-
tial amino acids (all from PAA Laboratories, Yeovil, Somerset, UK)
at 37C and 5% CO2.
Whole-Cell Patch Clamp
Whole-cell patch-clamping experiments on transiently trans-
fected HEK293 cells were performed as previously described.17
Patch pipettes were manufactured from soda glass capillary tubes
(VWR International, Lutterworth, Leicestershire, UK) on a PC10
two-stage vertical puller (Narishige, London). They had tip resis-
tances from 2 to 4 MU when ﬁlled with the pipette solution.
Conventional whole-cell recordings were made with the use of
a Multiclamp 700B ampliﬁer (MDS Analytical Technologies,
Wokingham, Berkshire, UK) in the voltage-clamp mode. Voltage
protocols were driven from a PC equipped with a Digidata
interface and pClamp 9 software (MDS Analytical Technologies).
The extracellular bath solution contained (mM) 140 NaCl,
2 CaCl2, 1 MgCl2, 10 glucose, 30 mannitol, 10 HEPES; pH 7.4
with NaOH. The pipette solution was a low Cl, high Ca2þ solu-
tion containing (mM) 20 CsCl, 110 Cs aspartate, 2 MgCl2,
10 glucose, 10 HEPES, 10 EGTA, and 7.2 CaCl2; pH adjusted to
7.2 with CsOH. Free Ca2þ concentration was calculated to be
approximately 0.5 mM with the use of the WEBMAXC program.
Csþ was included for the inhibition of Kþ currents, and Kþ was
omitted from all solutions. Voltage was stepped from 120 to
þ80 mV in þ20 mV increments and was applied for 450 ms
from a holding potential of 50 mV. Results are presented as
mean 5 standard error of the mean (SEM). Differences between
the data were analyzed by Kruskal-Wallis analysis of variance
(ANOVA) followed by Dunn’s multiple comparison.ber 13, 2009
Figure 1. Pedigree of Families
(A) Family 1 had a history of adRP. The proband is IV-13.
(B) Family 5. The proband (III-5) was diagnosed with adRP, but sequencing revealed that all tested affected family members were homo-
zygous for p.L140V. This suggests that the proband’s mother is heterozygous for the same mutation. Neither the proband’s mother nor
any of her unaffected siblings have reported or been diagnosed with symptoms of RP, suggesting that in this family RP is recessively
inherited. All ten coding exons and the ﬂanking intronic sequences of BEST1 were sequenced in the probands from each family. Family
members indicated with>were sequenced for the respective exon that wasmutated in the family proband (exon 5 in family 1 and exon
6 in family 5).Transient Transfection
MDCK II cells were seeded at a density of ~13 106 cells per well on
to 24 mm Transwell ﬁlters (Corning, Schiphol-Rijk, The
Netherlands) 24 hr prior to transfection. Cells were transfected
with 2 mg of plasmid DNA with the use of Lipofectamine 2000
Transfection Reagent (Invitrogen) in accordance with the manu-
facturer’s instructions. HEK293 cells were transiently transfected
as previously described.15 Cells were cotransfected with pAdlox
vector containing WT or mutant BEST1 and the empty vector
pEGFP-C1 in a 5:1 ratio with the use of Exgene500 in accordance
with themanufacturer’s instructions. Transfected cells were visual-




ature 48 hr after transfection. Primary antibodies were used at the
following concentrations: mouse monoclonal anti-bestrophin-1The American(NB300-164) at 1:2000 (Stratech Scientiﬁc, Newmarket, Suffolk,
UK) and rabbit polyclonal anti-ZO-1 at 1:1000 (Invitrogen;
61-7300). Secondary antibodies were goat anti-mouse IgG1 Alexa
Fluor 488 (Invitrogen; A21121), goat anti-rabbit IgG Alexa Fluor
594 (Invitrogen; A11012), and donkey anti-mouse IgG Texas Red
(Stratech; NB120-7059). MDCK II cells grown on Transwell
ﬁlters (Corning) were washed with phosphate-buffered saline
(PBS), ﬁxedwith 4%paraformaldehyde (in PBS) for 20min,washed
with PBS (33), quenched with 50 mM NH4Cl (in PBS) for 10 min,
permeabilizedwith 0.1% (v/v) TrionX-100 for 10min, andwashed
with PBS. Cells were then blocked for 30 min with 5% (v/v) fetal
calf serum in PBS (FBS/PBS) and were then incubated with the
appropriate primary antibody in FBS/PBS for 1 hr. Cells were then
washed for 5 min with FBS/PBS (33) before being incubated with
the appropriate secondary antibody in FBS/PBS for 1 hr at room
temperature and then washed with PBS at least three times for
5 min. The Transwell ﬁlters were then cut from the inserts andJournal of Human Genetics 85, 581–592, November 13, 2009 583
mounted onto microscope slides with AF1 anti-fadent solution
(Citiﬂuor, London, UK) with or without DAPI stain and sealed
with nail varnish.
Images were collected with a Nikon C1 confocal on an upright
90i microscope with a 60 3 1.40 Plan Apo objective and 33
confocal zoom. The confocal settings were as follows: pinhole,
30 mm; scan speed, 400 Hz unidirectional; format, 1024 3 1024.
Images for DAPI, Alexa Fluor 488, Alexa Fluor 594, and Texas
Red were excited with the 405 nm, 488 nm, and 594 nm laser lines
respectively. When 3D optical stacks were acquired, the confocal
software (Nikon EZ-C1) was used for determining the optimal
number of Z sections.
Results
Mapping of Family 1 to 11q13 and Sequencing
of BEST1
A nonconsanguineous white family of European descent
(family 1, Figure 1A) with a history of adRP underwent
SNP array and linkage analysis for the identiﬁcation of
the causal gene. Parametric linkage analysis was carried
out with seven affected and two unaffected family
members. A maximum LOD score of 2.9 was obtained on
chromosome 11, and no other chromosomes had a positive
LOD score (Figures S1–S6, available online). Haplotype
analysis showed a common inherited haplotype on chro-
mosome 11, between markers rs536715 and rs17304039,
giving a critical region of 64.9 Mb.
The critical region identiﬁed from linkage analysis in
family 1 included BEST1 which is mutated in several other
retinopathies. We therefore sequenced the coding region
of BEST1 in the proband IV-13 and found the previously
unreported heterozygous sequence variant c.614t>c
(p.I205T) in exon 5. The mutation segregated with the
adRP disease phenotype in nine other affected family
members and was absent from ﬁve unaffected family
members. No other genes in the critical region were
screened.
Sequencing BEST1 in adRP and Concentric
RP Panels
After the identiﬁcation of a BEST1mutation in this original
adRP family, we sought to identify additional BEST1muta-
tions in a panel of 95 adRP patients in whom nomutations
had been found in the following: RHO (MIM 180380), RDS
(MIM 608133),ORP1 (MIM 603937) (c.2029c>t [p.R677X],
c.2035c>t [p.R679X]), PAP1 (MIM 607331) (c.410a>t
[p.H137L]), PRPF31 (MIM 600138) (c.527þ3a>g; c.527þ
1g>t), IMPDH1 (MIM 180105) (exon 8), PRPF8 (MIM
600059) (exon 42), NRL (MIM 162080) (exon 1), NR2E3
(MIM 611131) (exons 2 and 3), and PRPF3 (MIM 601414)
(exon 11). In addition, because of the phenotypic overlap
between concentric RP22 and ADVIRC,15 we screened 12
individuals with concentric RP.
In the adRP panel, we identiﬁed mutations in two unre-
lated patients. The previously unreported BEST1mutation,
c.682g>a (p.D228N) in exon 6, was present as a heterozy-584 The American Journal of Human Genetics 85, 581–592, Novemgous change in the proband and his mother (family 3).
In family 5, a c.418c>g (p.L140V) homozygous change
in exon 4 was found in the proband, an affected sister,
and the father. The proband’s parents were from the
same village in Pakistan. We have previously found the
p.L140Vmutation in patients diagnosed with ARB (unpub-
lished data), and it is likely that the phenotype seen in
this family is actually ARB at an early time point (see
Discussion). We also found two heterozygous mutations
in apparently unrelated patients from the concentric RP
panel. In family 2, the female proband and her brother
had the same c.682g>a (p.D228N) change in exon 6 that
we had seen in family 3. The female proband in family 4
was heterozygous for a c.680a>g (p.Y227C) mutation in
exon 6 that has previously been reported as causal in two
cases of VMD.23,24 All previously unreported sequence
variations were absent from 210 ethnically matched
control chromosomes, as determined by SSCP.
Clinical Details
Family 1: Original adRP Family, Heterozygous c.614t>c,
p.I205T
Family 1 is a nonconsanguineous white family of European
descent (family 1, Figure 1A) with a history of adRP. In all
cases, affected individuals were noted to have reduced
central vision beginning at age 5–10 years and were
also noted to have night blindness. All patients were
highly hyperopic. Visual symptoms were progressive, and
blindness registration was generally around the end of
the second decade of life. The proband (patient IV-13 in
family 1, Figure 1A) fell down the stairs at age 13 mo, at
which stage she was noted to have bilateral total serous
retinal detachments associated with epiretinal membrane
formation and severe retinal gliosis. The optic discs were
pale, and there was no vessel attenuation. The remaining
individuals have been examined in late childhood or
adulthood; fundoscopy reveals a panretinal dystrophy
associated with ﬂecks in the midperiphery (autoﬂuores-
cence imaging was not performed), retinal gliosis and
severe vascular attenuation, but relatively little peripheral
pigment deposition, which is not typical of classical
RP but is consistent with a severe retinal dystrophy
affecting both rods and cones (Figures 2A and 2B). All
tested affected individuals had extinguished electroretino-
grams (ERGs) in the dark-adapted state with residual light-
adapted responses. This was the case for all affected family
members tested at all ages. As a result, EOG testing was
not performed.
Family 2: Concentric RP Panel, Heterozygous c.682g>a,
p.D228N
Family 2 is awhite family of Europeandescent. Two siblings
were diagnosed with RP at ~25 years of age. At age 30 years,
the female sibling (P1 in Milam et al.22) reported no night
blindness or visual ﬁeld loss. She had near-normal visual
acuity, high myopia, some constriction of the visual ﬁeld,
and subnormal rod and cone ERGs. The male sibling (P2
in Milam et al.22) had longstanding complaints ofber 13, 2009
Figure 2. Retinal Images
(A and B) Family 1. Fundus images of left
eyes of individual IV-15 (A), showing mid
peripheral ﬂecks (white arrows) and
pigment clumping (black arrows), and of
IV-1 (B), demonstrating severe vascular
attenuation (arrows) and disc pallor
(circled).
(C and D) Family 2. Fundus images of
affected siblings, showing the dense
pigmentary changes (black areas) that
were present in all quadrants of the
peripheral retina and the abrupt change
to a more-normal-appearing central retina
(arrows). Inferotemporal left retina of the
female proband (P1) at age 30 years (C)
and inferior left retina of the proband’s
brother (P2) at age 40 years (D).
(E and F) Family 3. Color fundus photos of
the posterior pole (top) and inferior retina
(bottom) of the right and left eyes of the
proband in family 3 (F), with normal auto-
ﬂuorescence imaging of the posterior poles
(E). Bone spiculation is seen in the periph-
eral retina only (arrows in F).
(G and H) Family 4. Fundus images of the
left (G) and right (H) eyes of the proband.
Note the abrupt demarcation between
normal (light areas) and abnormal (dark
areas) peripheral retina. RPE degeneration
and bone-spicule-like pigment clumping
(arrows) were present circumferentially in
both eyes.
(I–K) Family 5. Proband (III-5), 23 years of
age, showing total serous retinal detach-
ment in the right eye (arrows), with central
yellow deposit (I) and retinal detachment
extending nasally (J). Autoﬂuorescence
imaging in individual III-2, showing
increased signal in area of yellow deposits
(arrows) (K).peripheral visual loss but nonight blindness at age 40 years.
Therewas reduced visual acuity in the right eye as a result of
a posterior subcapsular cataract, near-normal visual acuity
in the left eye, constricted visual ﬁelds, and reduced rod
and cone ERGs. Both patients had vessel attenuation, dense
pigmentary change in all quadrants of the peripheral
retina, and an abrupt change to a more-normal-appearing
central retina (Figures 2C and 2D) (see also Figure 7 in Mi-
lam et al.22). There was no history of other affected family
members, but given the possibility of an autosomal-domi-
nant mode of inheritance in this family, it is of note that
a fundus examination of the father revealed peripheral
pigmentary changes in both eyes. The mother’s clinical
examination was normal. Samples for genotyping were
not available from the parents.
Family 3: adRP Panel, Heterozygous c.682g>a, p.D228N
Family 3 is a white family of European descent. The
proband reported the onset of night blindness in the ﬁfth
decade. He was noted to have a high degree of myopia,
asteroid hyalosis, and reduced visual acuity and visual ﬁeldThe Americanat age 58 years. The maculae appeared normal on clinical
examination, and this was supported by normal autoﬂuor-
escence imaging (Figure 2E) and ocular coherence tomog-
raphy. Intraretinal bone spicule pigmentation was present
in the peripheral retina only but without a sharp demarca-
tion between normal and abnormal retina (Figure 2F). The
affected mother was also heterozygous for c.682g>a but
was not seen in the clinic. Neither the proband nor his
mother underwent EOG or ERG testing, because these
could not be locally performed to ISCEV standards.
Family 4: Concentric RP Panel, Heterozygous c.680a>g,
p.Y227C
Family 4 is a white family of European descent. The
proband had minimal symptoms but was referred to the
clinic at age 45 years after a retinal examination by her
optometrist. Examination revealed an abrupt change
from normal to abnormal retina in the periphery, sugges-
tive of a bestrophinopathy (Figures 2G and 2H). After
molecular testing and the identiﬁcation of a heterozygous
p.Y227C mutation adjacent to the other concentric RPJournal of Human Genetics 85, 581–592, November 13, 2009 585
Figure 3. Multiple Alignment of Bestrophin-1 around the Residues Mutated in RP
The amino acid sequence of bestrophin-1 incorporating the four RP mutations (p.L140V, p.I205T, p.Y227C, p.D228N; shaded boxes) is
shown for ten orthologs (Homo sapiens, Pan troglodytes,Macacamulatta, Bos taurus, Canis familiaris,Musmusculus, Rattus norvegicus,Gallus
gallus,Xenopus tropicalis,Danio rerio) The alignmentwas performedwith ClustalW, and the sequence accession numbers are those quoted
in Milenkovic et al.49p.D228N mutation reported here, the fundus images were
found to be consistent with a diagnosis of concentric RP.
The probandwas unavailable for either ERG or EOG testing
and has two affected daughters with a similar phenotype,
who were unavailable for molecular testing.
Family 5: adRP Panel, Homozygous c.418c>g, p.L140V
Family 5 is a family of Pakistani origin. The proband (III-5
in family 5, Figure 1B) presented with night blindness and
central vision loss in her right eye at the age of 11 years.
Examination revealed a right total serous retinal detach-
ment with bilateral central retinal yellow foveal deposits
and macular edema (Figures 2I and 2J). Her visual acuities
at 23 years of age were recorded as counting ﬁngers (right
eye) and 6/36 (left eye). Electrophysiology testing revealed
no recordable pattern ERG, and extinguished or reduced
rod ‘‘a’’ and ‘‘b’’ wave responses and maximal bright
white ﬂash ERGs in the right and left eyes, respectively.
Cone responses were delayed with reduced amplitudes.
Her father and two sisters were also affected. (family 5,
Figure 1B). Her two affected sisters complained of nycta-
lopia and central visual loss as teenagers. Visual acuities
were 6/12 (right) and 6/7.5 (left) for individual III-2 at
age 30 years, and 6/12 (right) and 6/48 (left) for individual
III-8 at age 18 years. The pattern ERGs were extinguished
for subject III-8, and the rod and cone ERGs were also
abnormal. The father, patient II-6, had visual acuities of
6/120 (right and left) at age 55 years. At 23 years of age,
his visual acuities were severely reduced and electrophysi-
ology testing revealed no recordable pattern ERG, extin-
guished or reduced rod ‘‘a’’ and ‘‘b’’ wave responses and
maximal bright white ﬂash ERGs, and delayed cone
responses with reduced amplitudes.586 The American Journal of Human Genetics 85, 581–592, NovemAll three affected siblings and their affected father have
a similar phenotype, with bilateral macular edema and
yellow deposits concentrated at the macula, scattered in
the posterior pole, and characterized by an increased signal
on autoﬂuorescence (Figure 2K). Retinal degenerative
changes were seen in the father, who presented at age 41
years with yellow deposits, intraretinal bone spicule
pigmentation, and attenuated blood vessels.
Although the proband’s parents were not of a consan-
guineous marriage, they were from the same village. All
tested individuals (proband, father, and sister III-2) were
homozygous for the mutation c.418c>g (p.L140V). No
other family members were available for molecular testing.
Conservation of Mutated Residues
A multiple alignment of the region of bestrophin-1 con-
taining the four RP mutations reported here with nine
orthologs is shown in Figure 3. The tyrosine at position
227 and the aspartic acid at position 228 are both
conserved down to Danio rerio. The leucine at position
140 is conserved down toXenopus tropicalis but is a tyrosine
in D. rerio. The isoleucine at position 205 is conserved in
Pan troglodytes, Macaca mulatta, and Bos taurus but is
a valine in the other six species.
Whole-Cell Patch-Clamp Analysis of RP Mutant
Isoforms
Cells expressing WT bestrophin-1 exhibited large, out-
wardly rectifying-currents (Figure 4B) in comparison to
control cells transfected with eGFP (Figure 4A). Current
magnitudes were very much smaller in cells transfected
with the p.I205T mutant (Figure 4C). Current densitiesber 13, 2009
Figure 4. Cl Channel Activity Associated with the Expression of p.I205T and p.L140V in HEK293 Cells
(A–C)Whole-cell current records in cells transfected with (A) eGFP, (B) WT bestrophin-1, and (C) p.I205T. Currents were evoked with
450 ms voltage steps (Vm) from 120 mV to 80 mV in increments of 20 mV. The holding Vm was 50 mV.
(D) Current density is plotted as a function of Vm for cells transfected with WT bestrophin-1 (-; n ¼ 10), p.I205T (A; n ¼ 10), andWT
plus p.I205T (V; n ¼ 7).
(E) Outward conductances measured for combinations of WT and mutant bestrophins. Conductances were measured between Vm ¼
60–80 mV, and the values were normalized to the mean WT conductance for each series of experiments. In the p.L140V series of exper-
iments, the number of patched cells were as follows: WT, n ¼ 14; p.I205T, n ¼ 12; andWT plus p.I205T, n ¼ 14. Results are presented as
mean5 standard error of the mean. An asterisk denotes a signiﬁcant difference (p < 0.05).were only partially reduced in cells transfected with both
p.I205T and WT bestrophin-1 (Figure 4D). The reversal
potential was 19.5 5 2.5 mV for the WT bestrophin-1
(Figure 4D). This value is toward the ECl (equilibriumpoten-
tial for Cl calculatedwith theNernst equation) established
by our experimental solutions (34 mV) and is similar to
values we have previously determined for bestrophin-1.17
The reversal potentials for the currents carried by p.I205T
alone or by p.I205TplusWTwere not signiﬁcantly different
from the WT value (p > 0.1) (Figure 4D).
Whole-cell currents were greatly reduced or partially
reduced in cells transfected with p.L140V alone or cotrans-
fected with WT and p.L140V, respectively (Figure 4E).
Conductances observed with the expression of p.L140V
or p.I205T alone were signiﬁcantly reduced in comparison
to those observed in WT controls (p < 0.05). Cotransfec-
tion of either mutant with WT produced conductances
that were not signiﬁcantly reduced in comparison to
controls (p > 0.1). However, the conductance observed
with WT and p.L140V was signiﬁcantly greater than that
observed with p.L140V alone (p < 0.05) (Figure 4E).The AmericanCellular Localization of RP Mutant Isoforms
The localization of WT and RP-associated bestrophin-1
mutant isoforms were determined in polarized epithelial
MDCK II cells.WT bestrophin-1 localized to the basolateral
membrane of MDCKII cells and was exclusively basal to
the tight junction marker ZO-1 (Figure 5A). The p.I205T
mutant isoform had a cell-membrane localization similar
to that of the WT protein (Figure 5B). The localization
of mutant isoforms p.L140V and p.D228N exhibited
a signiﬁcant intracellular localization (Figures 5C and 5D
respectively), whereas the ARB mutation p.D312N has a
cytoplasmic localization (Figure 5F). Images from the com-
plete Z-stack were examined so that a lack of membrane
localization at any lateral level was ensured.
Discussion
To our knowledge this is the ﬁrst report of mutations in an
RPE gene, BEST1, in patients diagnosed with adRP. Families
1, 3, and 4 carry three different mutations, two of themJournal of Human Genetics 85, 581–592, November 13, 2009 587
Figure 5. Cellular Localization of Bestrophin-1 Isoforms in MDCK II and HEK293 Cells
Transiently transfected MDCK II cells (A–D and F) were polarized on Transwell membranes before immunoﬂuorescent labeling with be-
strophin-1 antibody (green in A–D and F) and confocal microscopy. Nuclei were labeled with DAPI (blue). A representative lateral (Z-
stack) image is shown. WT (A) and p.I205T (B) isoforms localized to the basolateral membrane. A vertical optical section shows that
WT bestrophin-1 (green) localizes basal to the tight junction maker ZO-1 (red) (insert, A). The p.L140V (C) and p.D228N (D) isoforms
exhibited a diffuse cytoplasmic localization. The p.D312Nmutant isoform has a cytoplasmic localization (E). WT bestrophin-1 (red) ex-
pressed in HEK-293 cells does not trafﬁc to the cell membrane (F).previously unreported, and have an autosomal-dominant
mode of inheritance. Family 2 had two affected siblings
with the same heterozygous mutation as that in family 3;
the fact that their father was affected suggested an auto-
somal-dominant inheritance pattern. The ﬁfth family
(family 5) has a two-generation history of RP, which could
be consistent with a dominant mode of inheritance
(family 5, Figure 1B), but molecular analysis has shown
the affected father and two affected daughters all to be
homozygous for the missense mutation p.L140V. The
mother, who is from the same village as the father, is
presumed to be heterozygous for the mutation, and
because neither the mother nor any of her other six chil-
dren have reported or have been diagnosed with symp-
toms of RP, it must be concluded that in this family the
disease is recessively inherited. Unfortunately, no other
family members were available for molecular testing for
conﬁrmation of this.
The four RP mutations reported here all lie within the
predicted cytoplasmic loop between transmembrane
domains 2 and 3,25 and three of them are within 24 resi-
dues of each other, two being adjacent. This clustering
within one domain of the bestrophin-1 protein suggests
that a speciﬁc interaction or function is disrupted by these
four mutations. To the best of our knowledge, this interac-588 The American Journal of Human Genetics 85, 581–592, Novembtion domain has not been previously reported, because
proteins previously identiﬁed as interacting with bestro-
phin-1, protein phosphatise 2A and the CaVb subunit,
interact with the cytoplasmic C-terminal tail, which is
distal to the fourth transmembrane domain.26,27 The pre-
dicted cytoplasmic loop containing the four RP mutations
also contains several other residues that are mutated in
either VMD or ARB,28 suggesting that a particular function
or interaction is disrupted when these residues are altered.
With the exception of ADVIRC, the genotype-phenotype
correlation with bestrophin-1 mutations is not straightfor-
ward. A very similar situation is seen in the peripherin/RDS
gene, mutations in which cause macular dystrophies, cone
and cone-rod dystrophy, and RP.29 Additionally, as with
the bestrophinopathies, the phenotypes associated with
peripherin/RDS mutations show a high degree of inter-
and intrafamilial variation.29
Sequence analysis of ten bestrophin-1 orthologs revealed
that three of the four residues (p.L140, p.Y227, and
p.D228) that were altered in the RP patients were highly
conserved, supporting the conclusion that the sequence
alterations are pathogenic (Figure 3). The fourth residue,
isoleucine at position 205, is conserved down to Bos taurus
but is a valine in the other species analyzed (isoleucine and
valine are both nonpolar, hydrophobic, and aliphaticer 13, 2009
residues). The change of this residue in family 1 from an
isoleucine to a threonine alters the residue to a small polar
one, which is likely to be functionally signiﬁcant.
In this study, we examined the functional consequences
of two of the bestrophin-1 mutations that cause RP on Cl
conductance and on protein localization: p.L140V (reces-
sive) and p.I205T (dominant). Whole-cell patch-clamp
data demonstrated that heterologous expression of the
p.I205T and p.L140V mutations produced greatly reduced
Cl currents in comparison to the WT bestrophin-1.
Cotransfection of the adRP p.I205T mutant isoform with
WT bestrophin-1 resulted in a Cl conductance that was
less than 50% of theWTand was not signiﬁcantly different
from that measured in the presence of the mutant alone
(p > 0.1). In contrast, cotransfection of the arRP p.L140V
mutant isoform with WT bestrophin-1 resulted in a Cl
conductance that was about 60% of theWTand was signif-
icantly greater than the conductance measured with
the mutant alone (p < 0.01; Figure 4). The behavior of
the two mutant isoforms is therefore consistent with the
dominant and recessive disorders with which they are
associated.
We tested the effect of three of the RP mutations on the
intracellular trafﬁcking of bestrophin-1 by using polarized
MDCK II cells. The choice of this model cell system is
important.MDCK II cells are themostwidely usedmamma-
lian cell system for studying cell trafﬁcking and polarity
because when they are grown on porous ﬁlters they model
a physiological polarized system.30 Previous information
about the trafﬁcking and localization of bestrophin-1 is
from experiments in nonpolarized HEK293 cells.31–34
These cells are easy to transfect and produce high levels of
protein in comparison to more specialized cells, such as
MDCK II cells. However, transient transfection in nonspe-
cialized cells can lead to misinterpretation of protein local-
ization,35 such that any conclusions drawn from such
studies should be considered with due caution.36 WT
bestrophin-1 does not trafﬁc correctly in HEK293 cells
(Figure 5E). The importance of studying the trafﬁcking of
proteins with a polarized distribution in a polarized cell
model has been demonstrated for several integral
membrane proteins, including CFTR. In HEK293 cells,
some mutant CFTR isoforms trafﬁc to the cell surface in
quantities sufﬁcient for generating speciﬁc currents
via whole-cell patch-clamping experiments.37 However,
when these mutant isoforms were studied in polarized
MDCK II cells, they were not detectable at the cell
surface.36,37 Similarly, bestrophin-1 p.D312N was detected
at normal, or above normal, levels at the cell surface of
HEK293 cells by a biotinylation assay,33 but we have found-
this isoform to be cytoplasmic in MDCK II cells (Figure 5F).
Thus, for future bestrophin-1 trafﬁcking studies, we suggest
that the use of an appropriate cell system, such as the polar-
ized MDCK II cells used here, should be a requirement.
MDCK II cells do, however, express an endogenous Ca2þ-
activated Cl conductance, so that HEK293 cells are still
preferred for electrophysiological studies.38The AmericanTwo of the three mutations analyzed, p.L140V (arRP)
and p.D228N (adRP), caused bestrophin-1 to mislocalize
from the basolateral membrane to the cytoplasm, and
this is likely to contribute to their pathogenicity. Impor-
tantly, the p.I205T mutation that causes a more severe,
earlier-onset, dominant retinal dystrophy had a similar
localization to that of theWT protein (Figure 5), suggesting
that membrane localization alone can explain neither the
pathogenesis of this group of mutations nor the differ-
ences in Cl conductance observed in this study.
The phenotype associated with each of the bestrophino-
pathies is distinct, and the lack of correlation between some
mutations and their functional behavior implies that addi-
tional factors need to be considered. These could include
a degree of redundancy provided by bestrophin-2.39
However, unpublished data cited by Marmorstein et al.40
show that bestrophin-2 is expressed not in the RPE but in
the nonpigmented epithelial cells of both mouse and
human retina and that a double knockout of Best1 and
Best2 does not lead to either a retinal degeneration or an
altered EOG. The null bestrophin-1 mouse and human
have distinct phenotypes,9,17 so it is likely that other factors
have a bearing on what phenotype is associated with
a particular mutation. These include other genes, the envi-
ronment, and how the cell machinery processes certain
mutations. The importance of protein processing is illus-
trated by the example of claudin 16, which has a predicted
topology similar to that of bestrophin-1. A study of 21
CLDN16 mutations that cause familial hypomagnesemia
with hypercalciuria and nephrocalcinosis (MIM 248250)
found that different mutations were processed in very
differentways.41Nine of themutant isoformswere retained
within the endoplasmic reticulum, and three accumulated
in the Golgi complex. Two mutant isoforms were detected
in lysosomes; of these one was retro-transported from the
cell surface, and the second nevermade it to the cell surface
at all. The remaining seven mutant isoforms were all
correctly trafﬁcked to tight junctions, although four were
defective in paracellular Mg2þ transport.41
An interesting observation in the present study is the
presence of retinal detachments in the probands of
two families (1 and 5). In the case of family 1, the
proband was found to have severe bilateral serous retinal
detachments at the age of 13 months. Exudative detach-
ment is a previously reported, but uncommon, feature
of the pseudohypopyon stage of VMD.42–46 Basolateral
membrane Cl conductance regulates ﬂuid transport
across the RPE and, consequently, the volume of the
subretinal space,47 and it has been suggested that disrup-
tion of ﬂuid absorption across the RPE may be partly
responsible for the etiology of diseases involving the RPE
and photoreceptors. In the case of serous retinal detach-
ments, this may occur by either a slowing or a reversal of
ﬂuid transport.47 Such a process has also been proposed
as part of the mechanism underlying the accumulation
of vitelliform pigment under the macula in the pseudohy-
popyon stage of VMD.6Journal of Human Genetics 85, 581–592, November 13, 2009 589
The identiﬁcation of the homozygous p.L140V muta-
tion in a family diagnosed with arRP and ARB (our unpub-
lished data) illustrates the increasingly complex clinical
picture associated with bestrophin-1 mutations. For some
mutations, such as p.L140V, it may be that the homozy-
gous state can manifest as ARB, and given the phenotypic
overlap between RP and ARB, it is also likely that clinicians
may misdiagnose cases of ARB as RP if they are not fully
aware of the ARB phenotype or see an ARB patient at
later disease stages. The critical region identiﬁed from
linkage analysis in family 1 overlaps with the locus for
autosomal-dominant neovascular inﬂammatory vitreore-
tinopathy (ADNIV), which is characterized by retinal and
iris neovascularization, abnormal retinal pigmentation,
anterior chamber and vitreous inﬂammation, cystoid
macular edema, vitreous hemorrhage, and traction retinal
detachment.48 The ADNIV phenotype is rare but appears
distinct from that seen in the family 1 patients who lack
neovascularisation, vitreous hemorrhage, and traction
retinal detachment. The ADNIV locus centers on marker
D11S527, which is 14.6 Mb distal to BEST1. The pheno-
type and mapping data both suggest that it is unlikely
that family 1 has ADNIV caused by mutations in an
unknown gene.
This study reports four missense mutations, three previ-
ously unreported, that are the cause of autosomal-domi-
nant, concentric, or autosomal-recessive RP and/or retinal
dystrophies in ﬁve unrelated families. Phenotypic hetero-
geneity is not uncommon in ocular disease, as a review
of the RetNet website clearly highlights. However, the situ-
ation with BEST1 is becoming increasingly complicated,
because ﬁve separate ocular diseases are now ascribed
to mutations in it (VMD, adult-onset VMD, ADVIRC,
ARB, and RP) and the same mutation can be causal in
multiple bestrophinopathies. Although the incidence of
each of these bestrophinopathies is individually rare, the
increasing number of phenotypes associated with BEST1
mutations suggests that it as an increasingly important
cause of genetic ocular disease.
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